Science Explorer Back to mapMap
Discussion
Researcher · AstraZeneca (United Kingdom) · United Kingdom

Alan Lau

Alan Lau publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as DNA Repair Mechanisms, PARP inhibition in cancer therapy and Cancer therapeutics and mechanisms.

ORCID 0000-0003-1055-9812 OpenAlex
World rank
#54,385
of 7,710,434 ranked researchers
Rank in United Kingdom
#4,494
of 367,258
Works
112
Citations
10k
Citations per work
91.8
h-index
38
i10-index 44Top 8.3% in Molecular Biology
Alan Lau

What does Alan Lau research?

Alan Lau's work is mostly in Biochemistry, Genetics and Molecular Biology (46%), Medicine (37%).

Life Sciences: 52 works · 46.0% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 46.0% of their workMolecular Biology: 42 works · 37.6% of their workGenetics: 5 works · 4.6% of their workCancer Research: 4 works · 3.8% of their workHealth Sciences: 42 works · 37.3% of their workMedicine: 42 works · 37.3% of their workOncology: 31 works · 27.4% of their workPulmonary and Respiratory Medicine: 6 works · 5.7% of their workGenetics: 5 works · 4.2% of their workEverything else: 19 works · 16.7% of their workTHEIR WORKAlan Lau112works
Life Sciences46%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5246.0%
    1. Medicine4237.3%
  3. Everything else1916.7%
  1. 1Molecular Biology38% of their works
  2. 2Oncology27% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Genetics5% of their works
  5. 5Genetics4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Alan Lau's research?

The keywords of their largest research topics: Homologous Recombination, Cancer Therapy, DNA Damage, Repair, BRCA Mutation, PARP Inhibitors, Breast Cancer and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Homologous Recombination992 topics
  2. Cancer Therapy562 topics
  3. DNA Damage531 topic
  4. Repair531 topic
  5. BRCA Mutation461 topic
  6. PARP Inhibitors461 topic
  7. Breast Cancer172 topics
  8. DNA121 topic
  9. Topoisomerases121 topic
  10. BRCA1101 topic
  11. BRCA2101 topic
  12. Cell Cycle101 topic
  13. p53101 topic
  14. CDK4/6 Inhibitors71 topic
  15. Chronic Lymphocytic Leukemia71 topic
  16. Genome Engineering71 topic
  17. Genomic Aberrations71 topic
  18. Palbociclib71 topic
  19. RNA-Guided71 topic

Where does Alan Lau work?

Alan Lau's main affiliation in the publication record is AstraZeneca (United Kingdom), United Kingdom.

How many publications and citations does Alan Lau have?

OpenAlex counts 112 works and 10,277 citations for Alan Lau, an h-index of 38, ranking #54,385 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alan Lau. Posts are plain text and can be reported.